Cocrystal Pharma (COCP) Competitors $1.50 -0.07 (-4.46%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$1.53 +0.03 (+2.00%) As of 08/29/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock COCP vs. GNTA, INMB, CUE, IMMX, SLGL, ALGS, ALXO, IVVD, ADVM, and ANLShould you be buying Cocrystal Pharma stock or one of its competitors? The main competitors of Cocrystal Pharma include Genenta Science (GNTA), INmune Bio (INMB), Cue Biopharma (CUE), Immix Biopharma (IMMX), Sol-Gel Technologies (SLGL), Aligos Therapeutics (ALGS), ALX Oncology (ALXO), Invivyd (IVVD), Adverum Biotechnologies (ADVM), and Adlai Nortye (ANL). These companies are all part of the "pharmaceutical products" industry. Cocrystal Pharma vs. Its Competitors Genenta Science INmune Bio Cue Biopharma Immix Biopharma Sol-Gel Technologies Aligos Therapeutics ALX Oncology Invivyd Adverum Biotechnologies Adlai Nortye Genenta Science (NASDAQ:GNTA) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Is GNTA or COCP more profitable? Genenta Science's return on equity of 0.00% beat Cocrystal Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Genenta ScienceN/A N/A N/A Cocrystal Pharma N/A -144.12%-102.85% Which has better valuation & earnings, GNTA or COCP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenenta ScienceN/AN/A-$9.64MN/AN/ACocrystal PharmaN/AN/A-$17.50M-$1.24-1.21 Which has more risk & volatility, GNTA or COCP? Genenta Science has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500. Do institutionals and insiders have more ownership in GNTA or COCP? 15.1% of Genenta Science shares are owned by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are owned by institutional investors. 29.0% of Genenta Science shares are owned by insiders. Comparatively, 28.1% of Cocrystal Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media refer more to GNTA or COCP? In the previous week, Genenta Science had 4 more articles in the media than Cocrystal Pharma. MarketBeat recorded 5 mentions for Genenta Science and 1 mentions for Cocrystal Pharma. Cocrystal Pharma's average media sentiment score of 1.88 beat Genenta Science's score of 0.51 indicating that Cocrystal Pharma is being referred to more favorably in the news media. Company Overall Sentiment Genenta Science Positive Cocrystal Pharma Very Positive Do analysts rate GNTA or COCP? Genenta Science presently has a consensus target price of $25.00, indicating a potential upside of 536.94%. Cocrystal Pharma has a consensus target price of $6.00, indicating a potential upside of 300.00%. Given Genenta Science's higher probable upside, equities analysts plainly believe Genenta Science is more favorable than Cocrystal Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genenta Science 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Cocrystal Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryGenenta Science beats Cocrystal Pharma on 7 of the 9 factors compared between the two stocks. Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COCP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCP vs. The Competition Export to ExcelMetricCocrystal PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.39M$3.08B$5.69B$9.74BDividend YieldN/A2.28%6.64%4.48%P/E Ratio-1.2120.9283.1926.59Price / SalesN/A352.35515.16159.07Price / CashN/A43.5325.6628.92Price / Book1.609.7811.766.08Net Income-$17.50M-$54.01M$3.27B$265.93M7 Day Performance-2.02%0.10%1.13%0.36%1 Month Performance-18.92%8.52%8.30%5.58%1 Year Performance-16.67%7.03%62.26%19.67% Cocrystal Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCPCocrystal Pharma3.0497 of 5 stars$1.50-4.5%$6.00+300.0%-16.7%$15.39MN/A-1.2110Positive NewsGNTAGenenta Science2.2957 of 5 stars$3.50-0.4%$25.00+615.3%+1.4%$64.20MN/A0.007Gap UpHigh Trading VolumeINMBINmune Bio2.248 of 5 stars$2.24-7.1%$18.40+721.4%-69.3%$64.07M$10K-0.9010CUECue Biopharma2.4578 of 5 stars$0.82-0.9%N/A+8.0%$63.47M$9.29M-1.4660High Trading VolumeIMMXImmix Biopharma3.2194 of 5 stars$2.10-4.1%$7.00+233.3%+3.7%$63.15MN/A-2.739Analyst DowngradeSLGLSol-Gel Technologies1.0147 of 5 stars$21.00-7.4%N/A+226.1%$63.15M$11.54M-17.0750Positive NewsGap DownALGSAligos Therapeutics4.2065 of 5 stars$10.21+0.1%$50.00+389.7%-16.8%$62.74M$3.94M-0.5290Positive NewsHigh Trading VolumeALXOALX Oncology3.0714 of 5 stars$1.10-6.0%$3.30+200.0%-49.6%$62.65MN/A-0.5040IVVDInvivyd3.9327 of 5 stars$0.56+7.6%$3.18+468.8%+14.4%$62.49M$25.38M-0.61100Gap UpHigh Trading VolumeADVMAdverum Biotechnologies4.2388 of 5 stars$3.03+2.0%$19.75+551.8%-55.6%$62.32M$1M-0.39190Positive NewsANLAdlai Nortye1.5654 of 5 stars$1.73+3.0%$9.00+421.7%-40.4%$61.82MN/A0.00127Positive NewsGap Down Related Companies and Tools Related Companies GNTA Competitors INMB Competitors CUE Competitors IMMX Competitors SLGL Competitors ALGS Competitors ALXO Competitors IVVD Competitors ADVM Competitors ANL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COCP) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cocrystal Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COCP Stock Alerts